RASGRP1 and T-cell leukemia: Particularly, in B-cell lymphomas and T-cell leukemias, RASGRP1 and CRAF, two HSP90 client proteins, are degraded upon HDAC6 inhibition, leading to RASGRP1/CRAF-dependent apoptosis [124].